Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1984 May;73(5):1335–1343. doi: 10.1172/JCI111336

Impaired formation of beta-adrenergic receptor-nucleotide regulatory protein complexes in pseudohypoparathyroidism.

J A Heinsimer, A O Davies, R W Downs, M A Levine, A M Spiegel, M K Drezner, A De Lean, K A Wreggett, M G Caron, R J Lefkowitz
PMCID: PMC425155  PMID: 6325502

Abstract

Decreased activity of the guanine nucleotide regulatory protein (N) of the adenylate cyclase system is present in cell membranes of some patients with pseudohypoparathyrodism (PHP-Ia) whereas others have normal activity of N (PHP-Ib). Low N activity in PHP-Ia results in a decrease in hormone (H)-stimulatable adenylate cyclase in various tissues, which might be due to decreased ability to form an agonist-specific high affinity complex composed of H, receptor (R), and N. To test this hypothesis, we compared beta-adrenergic agonist-specific binding properties in erythrocyte membranes from five patients with PHP-Ia (N = 45% of control), five patients with PHP-Ib (N = 97%), and five control subjects. Competition curves that were generated by increasing concentrations of the beta-agonist isoproterenol competing with [125I]pindolol were shallow (slope factors less than 1) and were computer fit to a two-state model with corresponding high and low affinity for the agonist. The agonist competition curves from the PHP-Ia patients were shifted significantly (P less than 0.02) to the right as a result of a significant (P less than 0.01) decrease in the percent of beta-adrenergic receptors in the high affinity state from 64 +/- 22% in PHP-Ib and 56 +/- 5% in controls to 10 +/- 8% in PHP-Ia. The agonist competition curves were computer fit to a "ternary complex" model for the two-step reaction: H + R + N in equilibrium HR + N in equilibrium HRN. The modeling was consistent with a 60% decrease in the functional concentration of N, and was in good agreement with the biochemically determined decrease in erythrocyte N protein activity. These in vitro findings in erythrocytes taken together with the recent observations that in vivo isoproterenol-stimulated adenylate cyclase activity is decreased in patients with PHP (Carlson, H. E., and A. S. Brickman, 1983, J. Clin. Endocrinol. Metab. 56:1323-1326) are consistent with the notion that N is a bifunctional protein interacting with both R and the adenylate cyclase. It may be that in patients with PHP-Ia a single molecular and genetic defect accounts for both decreased HRN formation and decreased adenylate cyclase activity, whereas in PHP-Ib the biochemical lesion(s) appear not to affect HRN complex formation.

Full text

PDF
1335

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bourne H. R., Kaslow H. R., Brickman A. S., Farfel Z. Fibroblast defect in pseudohypoparathyroidism, type I: reduced activity of receptor-cyclase coupling protein. J Clin Endocrinol Metab. 1981 Sep;53(3):636–640. doi: 10.1210/jcem-53-3-636. [DOI] [PubMed] [Google Scholar]
  2. Carlson H. E., Brickman A. S. Blunted plasma cyclic adenosine monophosphate response to isoproterenol in pseudohypoparathyroidism. J Clin Endocrinol Metab. 1983 Jun;56(6):1323–1326. doi: 10.1210/jcem-56-6-1323. [DOI] [PubMed] [Google Scholar]
  3. Carlson H. E., Brickman A. S., Bottazzo G. F. Prolactin deficiency in pseudohypoparathyroidism. N Engl J Med. 1977 Jan 20;296(3):140–144. doi: 10.1056/NEJM197701202960304. [DOI] [PubMed] [Google Scholar]
  4. Chase L. R., Melson G. L., Aurbach G. D. Pseudohypoparathyroidism: defective excretion of 3',5'-AMP in response to parathyroid hormone. J Clin Invest. 1969 Oct;48(10):1832–1844. doi: 10.1172/JCI106149. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Davies A. O., De Lean A., Lefkowitz R. J. Myocardial beta-adrenergic receptors from adrenalectomized rats: impaired formation of high-affinity agonist-receptor complexes. Endocrinology. 1981 Feb;108(2):720–722. doi: 10.1210/endo-108-2-720. [DOI] [PubMed] [Google Scholar]
  6. De Lean A., Stadel J. M., Lefkowitz R. J. A ternary complex model explains the agonist-specific binding properties of the adenylate cyclase-coupled beta-adrenergic receptor. J Biol Chem. 1980 Aug 10;255(15):7108–7117. [PubMed] [Google Scholar]
  7. DeLean A., Munson P. J., Rodbard D. Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves. Am J Physiol. 1978 Aug;235(2):E97–102. doi: 10.1152/ajpendo.1978.235.2.E97. [DOI] [PubMed] [Google Scholar]
  8. Drezner M. K., Burch W. M., Jr Altered activity of the nucleotide regulatory site in the parathyroid hormone-sensitive adenylate cyclase from the renal cortex of a patient with pseudohypoparathyroidism. J Clin Invest. 1978 Dec;62(6):1222–1227. doi: 10.1172/JCI109242. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Farfel Z., Bourne H. R. Deficient activity of receptor-cyclase coupling protein in platelets of patients with pseudohypoparathyroidism. J Clin Endocrinol Metab. 1980 Nov;51(5):1202–1204. doi: 10.1210/jcem-51-5-1202. [DOI] [PubMed] [Google Scholar]
  10. Farfel Z., Brickman A. S., Kaslow H. R., Brothers V. M., Bourne H. R. Defect of receptor-cyclase coupling protein in psudohypoparathyroidism. N Engl J Med. 1980 Jul 31;303(5):237–242. doi: 10.1056/NEJM198007313030501. [DOI] [PubMed] [Google Scholar]
  11. GREENWOOD F. C., HUNTER W. M., GLOVER J. S. THE PREPARATION OF I-131-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY. Biochem J. 1963 Oct;89:114–123. doi: 10.1042/bj0890114. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Kaslow H. R., Farfel Z., Johnson G. L., Bourne H. R. Adenylate cyclase assembled in vitro: cholera toxin substrates determine different patterns of regulation by isoproterenol and guanosine 5'-triphosphate. Mol Pharmacol. 1979 May;15(3):472–483. [PubMed] [Google Scholar]
  13. Kent R. S., De Lean A., Lefkowitz R. J. A quantitative analysis of beta-adrenergic receptor interactions: resolution of high and low affinity states of the receptor by computer modeling of ligand binding data. Mol Pharmacol. 1980 Jan;17(1):14–23. [PubMed] [Google Scholar]
  14. Kruse K., Gutekunst B., Kracht U., Schwerda K. Deficient prolactin response to parathyroid hormone in hypocalcemic and normocalcemic pseudohypoparathyroidism. J Clin Endocrinol Metab. 1981 Jun;52(6):1099–1105. doi: 10.1210/jcem-52-6-1099. [DOI] [PubMed] [Google Scholar]
  15. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  16. Levine M. A., Downs R. W., Jr, Moses A. M., Breslau N. A., Marx S. J., Lasker R. D., Rizzoli R. E., Aurbach G. D., Spiegel A. M. Resistance to multiple hormones in patients with pseudohypoparathyroidism. Association with deficient activity of guanine nucleotide regulatory protein. Am J Med. 1983 Apr;74(4):545–556. doi: 10.1016/0002-9343(83)91008-2. [DOI] [PubMed] [Google Scholar]
  17. Levine M. A., Downs R. W., Jr, Singer M., Marx S. J., Aurbach G. D., Spiegel A. M. Deficient activity of guanine nucleotide regulatory protein in erythrocytes from patients with pseudohypoparathyroidism. Biochem Biophys Res Commun. 1980 Jun 30;94(4):1319–1324. doi: 10.1016/0006-291x(80)90563-x. [DOI] [PubMed] [Google Scholar]
  18. Levine M. A., Eil C., Downs R. W., Jr, Spiegel A. M. Deficient guanine nucleotide regulatory unit activity in cultured fibroblast membranes from patients with pseudohypoparathyroidism type I. a cause of impaired synthesis of 3',5'-cyclic AMP by intact and broken cells. J Clin Invest. 1983 Jul;72(1):316–324. doi: 10.1172/JCI110971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Limbird L. E., Gill D. M., Lefkowitz R. J. Agonist-promoted coupling of the beta-adrenergic receptor with the guanine nucleotide regulatory protein of the adenylate cyclase system. Proc Natl Acad Sci U S A. 1980 Feb;77(2):775–779. doi: 10.1073/pnas.77.2.775. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Lindall A. W., Wong E. T. Column chromatography of human serum parathyroid immunoreactive peptides. Proc Soc Exp Biol Med. 1975 Mar;148(3):799–804. doi: 10.3181/00379727-148-38635. [DOI] [PubMed] [Google Scholar]
  21. Marx S. J., Hershman J. M., Aurbach G. D. Thyroid dysfunction in pseudohypoparathyroidism. J Clin Endocrinol Metab. 1971 Nov;33(5):822–828. doi: 10.1210/jcem-33-5-822. [DOI] [PubMed] [Google Scholar]
  22. Marx S. J., Sharp M. E., Krudy A., Rosenblatt M., Mallette L. E. Radioimmunoassay for the middle region of human parathyroid hormone: studies with a radioiodinated synthetic peptide. J Clin Endocrinol Metab. 1981 Jul;53(1):76–84. doi: 10.1210/jcem-53-1-76. [DOI] [PubMed] [Google Scholar]
  23. Ross E. M., Gilman A. G. Biochemical properties of hormone-sensitive adenylate cyclase. Annu Rev Biochem. 1980;49:533–564. doi: 10.1146/annurev.bi.49.070180.002533. [DOI] [PubMed] [Google Scholar]
  24. Ross E. M., Maguire M. E., Sturgill T. W., Biltonen R. L., Gilman A. G. Relationship between the beta-adrenergic receptor and adenylate cyclase. J Biol Chem. 1977 Aug 25;252(16):5761–5775. [PubMed] [Google Scholar]
  25. Sager G. Receptor binding sites for beta-adrenergic ligands on human erythrocytes. Biochem Pharmacol. 1982 Jan 1;31(1):99–104. doi: 10.1016/0006-2952(82)90243-x. [DOI] [PubMed] [Google Scholar]
  26. Salomon Y., Londos C., Rodbell M. A highly sensitive adenylate cyclase assay. Anal Biochem. 1974 Apr;58(2):541–548. doi: 10.1016/0003-2697(74)90222-x. [DOI] [PubMed] [Google Scholar]
  27. Shapiro M. S., Bernheim J., Gutman A., Arber I., Spitz I. M. Multiple abnormalities of anterior pituitary hormone secretion in association with pseudohypoparathyroidism. J Clin Endocrinol Metab. 1980 Sep;51(3):483–487. doi: 10.1210/jcem-51-3-483. [DOI] [PubMed] [Google Scholar]
  28. Stadel J. M., De Lean A., Lefkowitz R. J. Molecular mechanisms of coupling in hormone receptor-adenylate cyclase systems. Adv Enzymol Relat Areas Mol Biol. 1982;53:1–43. doi: 10.1002/9780470122983.ch1. [DOI] [PubMed] [Google Scholar]
  29. Stadel J. M., De Lean A., Mullikin-Kilpatrick D., Sawyer D. D., Lefkowitz R. J. Catecholamine-induced desensitization in turkey erythrocytes: cAMP mediated impairment of high affinity agonist binding without alteration in receptor number. J Cyclic Nucleotide Res. 1981;7(1):37–47. [PubMed] [Google Scholar]
  30. Steer M. L., Atlas D. Demonstration of human platelet beta-adrenergic receptors using 125I-labeled cyanopindolol and 125I-labeled hydroxybenzylpindolol. Biochim Biophys Acta. 1982 Apr 7;686(2):240–244. doi: 10.1016/0005-2736(82)90118-3. [DOI] [PubMed] [Google Scholar]
  31. Stiles G. L., Stadel J. M., De Lean A., Lefkowitz R. J. Hypothyroidism modulates beta adrenergic receptor adenylate cyclase interactions in rat reticulocytes. J Clin Invest. 1981 Dec;68(6):1450–1455. doi: 10.1172/JCI110397. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Williams L. T., Snyderman R., Lefkowitz R. J. Identification of beta-adrenergic receptors in human lymphocytes by (-) (3H) alprenolol binding. J Clin Invest. 1976 Jan;57(1):149–155. doi: 10.1172/JCI108254. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Wolfsdorf J. I., Rosenfield R. L., Fang V. S., Kobayashi R., Razdan A. K., Kim M. H. Partial gonadotrophin-resistance in pseudohypoparathyroidism. Acta Endocrinol (Copenh) 1978 Jun;88(2):321–328. doi: 10.1530/acta.0.0880321. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES